Latest Updates on Tort Cases

Read our latest blog posts for valuable legal insights.

Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link

Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link – AboutLawsuits.com Skip Navigation Source link...

Accelerate clinical trials with a connected financial ecosystem

By Rajesh Patel, senior director of product management, clinical trial financial suite, IQVIA The complex nature of clinical trial finances...

Leading the Age of AI: Balancing Empathy, Innovation, and Human Connection

Artificial intelligence is redefining industries at an unprecedented pace—and healthcare is no exception. But as algorithms grow smarter and adoption...

Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue

Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue – AboutLawsuits.com Skip Navigation...

Peptide Synthesis and the Hidden Complexities of Scaling Peptide Therapeutics

Sequence Risks That Escalate with Scale  A peptide sequence that performs well at micromole scale may behave unpredictably at gram...

Addressing Six Prevalent Mid-Market Biopharma Company Challenges by Upping Your ERP Game

Addressing Six Prevalent Mid-Market Biopharma Company Challenges by Upping Your ERP Game Start-up and midmarket biopharma companies can overcome...

Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors

Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors – AboutLawsuits.com Skip Navigation Source link...

Bridging the patient-provider gap with 360° data

For all the investment that pharma makes in engaging patients and providers, the disconnect at the point of care remains...

Hair Loss Drug Propecia’s Depression, Suicide Risks Overlooked for Years: Report

Hair Loss Drug Propecia’s Depression, Suicide Risks Overlooked for Years: Report – AboutLawsuits.com Skip Navigation Source link...
Scroll to Top